INNOVACAP2024-10-012024-12-31 INNOVACAP2024-10-012024-12-31 INNOVACAP2024-10-012024-12-31in-bse-fin:OneOperatingExpenses01Member INNOVACAP2024-10-012024-12-31in-bse-fin:OneOperatingExpenses02Member INNOVACAP2024-10-012024-12-31in-bse-fin:OneOperatingExpenses03Member INNOVACAP2024-10-012024-12-31in-bse-fin:OneOperatingExpenses04Member INNOVACAP2024-10-012024-12-31in-bse-fin:OneOperatingExpenses05Member INNOVACAP2024-10-012024-12-31in-bse-fin:OneOperatingExpenses06Member INNOVACAP2024-10-012024-12-31in-bse-fin:OneOperatingExpenses07Member INNOVACAP2024-10-012024-12-31in-bse-fin:OneOperatingExpenses08Member INNOVACAP2024-10-012024-12-31in-bse-fin:OneOperatingExpenses09Member INNOVACAP2024-10-012024-12-31in-bse-fin:OneOperatingExpenses10Member INNOVACAP2024-10-012024-12-31in-bse-fin:FourOperatingExpenses01Member INNOVACAP2024-10-012024-12-31in-bse-fin:FourOperatingExpenses02Member INNOVACAP2024-10-012024-12-31in-bse-fin:FourOperatingExpenses03Member INNOVACAP2024-10-012024-12-31in-bse-fin:FourOperatingExpenses04Member INNOVACAP2024-10-012024-12-31in-bse-fin:FourOperatingExpenses05Member INNOVACAP2024-10-012024-12-31in-bse-fin:FourOperatingExpenses06Member INNOVACAP2024-10-012024-12-31in-bse-fin:FourOperatingExpenses07Member INNOVACAP2024-10-012024-12-31in-bse-fin:FourOperatingExpenses08Member INNOVACAP2024-10-012024-12-31in-bse-fin:FourOperatingExpenses09Member INNOVACAP2024-10-012024-12-31in-bse-fin:FourOperatingExpenses10Member INNOVACAP2024-12-31 iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 544067 INNOVACAP NOTLISTED Innova Captab Limited Equity 2024-04-01 2025-03-31 2025-02-05 2025-01-29 INR Millions Third quarter 14:30:00 15:53:00 2025-02-05 2025-02-05 Not applicable Single segment Drugs and Pharmaceutical products 2024-10-01 2024-12-31 Unaudited Standalone 2485250000.00 34940000.00 2520190000.00 1751170000.00 1330000.00 79460000.00 147500000.00 1330000.00 30790000.00 180880000.00 2192460000.00 327730000.00 0.00 327730000.00 62820000.00 20890000.00 83710000.00 0.00 244020000.00 0.00 0.00 0.00 0.00 244020000.00 -1250000.00 242770000.00 0.00 0.00 572250000.00 10 4.26 4.26 0.00 0.00 4.26 4.26 1. The above standalone financial results of Innova Captab Limited ( the Company ) have been prepared in accordance with and comply in all material aspects with the Indian Accounting Standards (Ind AS) notified under Section 133 of the Companies Act, 2013 ( the act ) read with relevant rules issued there under and in terms of Regulation 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulation), as amended. 2. The above standalone financial results have been reviewed and recommended by Audit Committee at its meeting held on 05 February 2025. The Board of Directors at their meeting held on 05 February 2025 have approved the above results and taken them on record. The statutory auditors of the Company have expressed an unmodified review conclusion on the standalone financial results for the quarter and nine months ended 31 December 2024. 3. The Company has only one reportable segment i.e. “Drugs and pharmaceutical products” as per Ind-AS 108 Operating Segments specified under section 133 of the Companies Act, 2013. Single segment 2024-04-01 2024-12-31 Unaudited Standalone 7155390000.00 124190000.00 7279580000.00 5280920000.00 4500000.00 22650000.00 414220000.00 2990000.00 92030000.00 491910000.00 6309220000.00 970360000.00 0.00 970360000.00 192590000.00 54320000.00 246910000.00 0.00 723450000.00 0.00 0.00 0.00 0.00 723450000.00 -2800000.00 720650000.00 0.00 0.00 572250000.00 10 12.64 12.64 0.00 0.00 12.64 12.64 Bad debts written off 0.00 Expected credit loss on trade receivables -3500000.00 House keeping expense 6830000.00 Lab consumables 11390000.00 Miscellaneous expenses 76760000.00 Packing charges 23920000.00 Power and fuel 31730000.00 Rates, fees and taxes 5170000.00 Repair & Maintainance 10800000.00 Stores and spares consumed 17780000.00 Bad debts written off 18450000.00 Expected credit loss on trade receivables 18690000.00 House keeping expense 18460000.00 Lab consumables 29260000.00 Miscellaneous expenses 131250000.00 Packing charges 66740000.00 Power and fuel 96480000.00 Rates, fees and taxes 22060000.00 Repair & Maintainance 39200000.00 Stores and spares consumed 51320000.00 The Company's operations relate to only one reportable segment viz Drugs and Pharmaceuticals. Accordingly, no separate disclosure of segment information is required. -1680000.00 -3760000.00 -430000.00 -960000.00